Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in MADRIGAL PHARMACEUTICALS INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 23,846 shares of MDGL (MADRIGAL PHARMACEUTICALS INC), worth $13.9M as of 2025-Q4. The position was increased (++1.6% shares). MDGL represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$13.9M
Current Shares
23,846
Total Value Change
+$7M
Total Shares Change
-763
Other major holders of MDGL: BNP PARIBAS FINANCIAL MARKETS, BAKER BROS. ADVISORS LP, RTW INVESTMENTS, LP, VANGUARD GROUP INC, Avoro Capital Advisors LLC
Increased |
| 23,846 |
+1.6% |
| $13.9M |
| 0.0% |
| $583.73 |
28 |
| 2025-Q3 | Decreased | 23,476 | -41.0% | $10.8M | 0.0% | $443.10 | 0 |
| 2025-Q2 | Increased | 39,809 | +51.0% | $12M | 0.0% | $300.75 | 39 |
| 2025-Q1 | Decreased | 26,363 | -4.3% | $8.7M | 0.0% | $327.87 | 0 |
| 2024-Q4 | Increased | 27,538 | +23.2% | $8.5M | 0.0% | $311.62 | 33 |
| 2024-Q3 | Decreased | 22,356 | -9.2% | $4.7M | 0.0% | $212.43 | 0 |
| 2024-Q2 | Increased | 24,609 | +72.9% | $6.9M | 0.0% | $280.16 | 41 |